An HIV Vaccine is within reach
An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week’s BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships.
Equitable public-private partnerships between researchers, manufacturers, and distributors and partnerships between rich and poor countries are the best strategy for the development of the vaccine, say the authors. Successful vaccine development also entails adequate investment in the countries that carry the burden of the HIV/AIDS pandemic.
Vaccines are the only hope for the control and possible elimination of HIV infection. How we distribute the vaccine will also be a test of our international ethics and humanitarian objectives, they write.
If we fail to provide the world with an effective HIV vaccine, future generations will judge us harshly, because this failure will not be due to lack of ability or resources but to politics, they conclude.
All latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Seeing cancer’s spread through a computational window
Computational model allows researchers to simulate cellular-scale interactions across unprecedented distances in the human vasculature. Biomedical engineers at Duke University have significantly enhanced the capabilities of a computational model that…
Compact accelerator technology achieves major energy milestone
Particle accelerators hold great potential for semiconductor applications, medical imaging and therapy, and research in materials, energy and medicine. But conventional accelerators require plenty of elbow room — kilometers —…